DeltaShares S&P 400 Managed Risk ETF
DMRM
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- DE United States of America
- IPO Date
- Jul 31, 2017
- CIK
- 0001673996
- Similar Companies
- Business
- DeltaShares S&P 400 Managed Risk ETF (DMRM) is an exchange-traded fund that seeks to track the investment results of the S&P 400 Managed Risk 2.0 Index by providing dynamic exposure to U.S. mid-cap equities from the S&P MidCap 400 Index, 5-year U.S. Treasuries, and T-bills, with allocations adjusted to maintain a targeted volatility level and mitigate downside risk. The fund's portfolio typically includes a mix of cash equivalents (approximately 60%), U.S. listed stocks (around 39%), and minor international holdings, with top sectors encompassing government securities, finance, producer manufacturing, and electronic technology. DMRM trades on the NYSE Arca exchange under the ticker DMRM and pays quarterly dividends, recently distributing $0.32 per share. The ETF is issued by Transamerica ETF Trust and managed by Transamerica Asset Management, Inc., an SEC-registered investment adviser and indirect subsidiary of Aegon N.V., with Milliman Financial Risk Management LLC serving as sub-adviser. Launched in 2017 as part of the DeltaShares suite of strategic beta ETFs designed to deliver managed risk outcomes across equity indexes. The fund operates primarily in the U.S. market, targeting investors seeking capital appreciation with low volatility strategies in the asset allocation and mid-cap blend equities segments. In recent developments, Transamerica planned to close and liquidate DMRM along with four other DeltaShares ETFs in 2022 due to insufficient assets and traction, with liquidation announcements issued in March 2022. However, as of December 2025, DMRM continues to trade actively on the NYSE at approximately $55.22 per share, with a market capitalization of about $4.42 million and ongoing performance reporting. No major partnerships, acquisitions, funding rounds, or new product launches specific to DMRM have been reported in the last 1-2 years, reflecting a focus on sustained operations amid a small-scale presence.